Noticias de PFE_US

Mercado

Noticias del mercado

Últimas noticias sobre PFE_US — 665 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: PFE_US ✕ 665 resultados
07/09/2026 PFE_US — Mid-Day
Novartis India to acquire Pfizer trademarks 'Minipress' and 'Minipres' for Rs 1,250 crore

Novartis India will acquire trademarks registered in India and certain related intellectual property rights for Rs 1,250 crore

07/09/2026 PFE_US — Business Standard
Novartis India to acquire Pfizer's 'Minipress' trademark for ₹1,250 crore

The company has executed an asset purchase agreement and trademark assignment deeds with Pfizer Inc USA and Pfizer Products Inc USA

07/09/2026 PFE_US — NewsBytes
Novartis India buys Minipress, Minipres rights from Pfizer for ₹1,250cr

Novartis India will acquire the trademarks and intellectual property rights of Minipress, Pfizer’s hypertension drug, for ₹1,250 crore in a deal approved on September 7.

07/09/2026 PFE_US — Whalesbook
Novartis India Buys Minipress From Pfizer For ₹1,250 Crore

Novartis India acquires Minipress brand from Pfizer for ₹1,250 crore. Learn about the deal details, brand revenue, valuation, and potential risks for investors.

07/09/2026 PFE_US — The Economic Times
Novartis India to acquire Pfizer's 'Minipress' trademark for Rs 1,250 crore

Novartis India will acquire the Minipress and Minipres trademarks and related intellectual property from Pfizer for about ₹1,250 crore. Minipress XL, used for hypertension and benign prostatic hyperplasia, generated ₹228.6 crore in revenue as of July 2026, according to IQVIA data.

07/09/2026 PFE_US — Business Upturn
Pfizer to cease Minipress XL operations, secures USD 13.9 million from US parent

Pfizer Limited ends Minipress XL sale operations, receives USD 13.9 million payout from Pfizer Inc. USA post manufacturing halt.

07/09/2026 PFE_US — Business Today
Novartis India shares jump 4% on Rs 1,250 crore Pfizer trademarks acquisition

Novartis India said its board approved the transaction at a meeting held on September 7. The company subsequently executed an asset purchase agreement and trademark assignment deeds with Pfizer Inc. and Pfizer Products Inc. USA.

07/09/2026 PFE_US — Free Press Journal
Novartis India Buys Minipress Brand For ₹1,250 Crore, Pfizer To Stop Selling Hypertension Drug

Novartis India will acquire Pfizer’s Minipress and Minipres brands for Rs 1,250 crore as Pfizer stops selling the hypertension medicine in India.

07/09/2026 PFE_US — BusinessLine
Novartis India Ltd to acquire BP drug trademarks from Pfizer Inc, for ₹1,250 crore

Novartis India acquires BP drug trademarks from Pfizer for ₹1,250 crore, following ChrysCapital's stake acquisition.

07/09/2026 PFE_US — InvestyWise
Pfizer to Discontinue Minipress XL, Receives $13.9M

Pfizer Limited will stop selling Minipress XL on Sept 7, 2026, following its parent company's decision to halt manufacturing. Pfizer Limited will receive a $13.9 million payment.

07/09/2026 PFE_US — CNBC TV18
Novartis India to acquire Minipress, Pfizer’s high blood pressure drug, for ₹1,250 crore

Pfizer said on Monday that it will discontinue the marketing, distribution and sale of Minipress XL in India with effect from September 7, 2026.

07/09/2026 PFE_US — Sahi
Pfizer Limited To Stop Selling Minipress XL; To Receive ₹131.38 Crore Payment

Pfizer Limited is immediately discontinuing the marketing, distribution, and sale of Minipress XL in India due to global manufacturing cessation by Pfizer Inc.

07/09/2026 PFE_US — scanx.trade
Novartis India acquires Pfizer Minipress IP rights for ₹1,250 crore

Novartis India acquires Minipress and Minipres trademarks from Pfizer. Total consideration for the deal stands at ₹1,250.001 crore. Board approved the transaction on September 7, 2026. Minipress XL generated ₹228.6 crore revenue as per July 2026 data.

07/09/2026 PFE_US — scanx.trade
Pfizer discontinues Minipress XL sales, to receive $13.9 million

Pfizer Limited discontinues Minipress XL sales effective September 7, 2026. Decision follows Pfizer Inc. USA halting manufacture of the product. Company to receive $13.9 million (~₹131.38 crore) lump sum payment. Transaction approved by Board of Directors in meeting on September 7, 2026.

07/09/2026 PFE_US — Whalesbook
Pfizer Ltd to Discontinue Minipress XL; Receives Rs 131 Crore Compensation

Pfizer Ltd to discontinue Minipress XL from Sept 2026. Company to receive Rs 131.38 crore one-time compensation from parent Pfizer Inc. USA.

Página 29 de 34